FDA Adverse Event Injury Summary report: N

XEN 45 GTS

MDR report key: 11825624 · Received May 14, 2021

Report

Report Number
3011299751-2021-00165
Event Type
Injury
Date Received
May 14, 2021
Date of Event
February 28, 2021
Report Date
May 14, 2021
Manufacturer
ALLERGAN (IRVINE)
Product Code
KYF
PMA / PMN Number
K161457
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MD, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ARTICLE CITATION: ASANAD S., KALARN S., KALEEM, M. "POSTOPERATIVE COMPLICATIONS OF AB-INTERNO XEN IMPLANTATION IN PRIMARY ANGLE CLOSURE GLAUCOMA." AM J CLIN EXP IMMUNOL, VOL. 10, NO. 1, 2021, 44-47. WWW.AJCEI.US. ISSN: 2164-7712. FACILITY NAME: MEDICINE. FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT, PRODUCT, OR PATIENT DETAILS HAS BEEN REQUESTED. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. THE EVENTS OF GEL STENT BLOCKAGE AND DEVICE MIGRATION ARE ADDRESSED IN THE PRODUCT LABELING.

Description of Event or Problem · 1

REPORTED EVENTS OF "BY SIX WEEKS POST-IMPLANT, SLIT LAMP BIOMICROSCOPY REVEALED OBSTRUCTION OF THE STENT LUMEN BY THE IRIS ALONG WITH IRIS PIGMENT DEPOSITS TRAVERSING TO THE DISTAL CONJUNCTIVAL END OF THE STENT WITHIN THE BLEB. THE INTRAOCULAR PRESSURE (IOP) HAD INCREASED TO 24 MMHG. STENT WAS NOTED TO BE DISLOCATED AND CURLED AGAINST THE IRIS WITHOUT CORNEAL TOUCH. RESTARTED ON GLAUCOMA MEDICATIONS AND SCHEDULED FOR REVISION SURGERY. DURING REPOSITIONING VIA AB-EXTERNO APPROACH, STENT WAS DECAPITATED. STENT THEN REMOVED AND IOP LOWERED TO 10 MMHG. IOP REMAINS STABLE WITHOUT GLAUCOMA MEDICATIONS AND RESIDUAL IRIS ATROPHY" WERE NOTED IN THE ARTICLE: "POSTOPERATIVE COMPLICATIONS OF AB-INTERNO XEN IMPLANTATION IN PRIMARY ANGLE CLOSURE GLAUCOMA." AM J CLIN EXP IMMUNOL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
720887 XEN 45 GTS IMPLANT, EYE VALVE KYF ALLERGAN (IRVINE) NI

Patients

Seq Age Sex Outcome Treatment
1 86 YR Required Intervention